Warning letter
LifeServe Blood Center: warning letter of Aug 9, 2013
FDA warning letter 407983 · Kansas City District Office
Key facts
| Reference number | 407983 |
|---|---|
| Company | LifeServe Blood Center |
| Subject | CGMP Blood & Blood Components/Adulterated |
| Issue date | Aug 9, 2013 |
| Posted date | Aug 9, 2013 |
| Issuing office | Kansas City District Office |
| Product type | Biologics |
| CFR sections cited | 610.40(h)(1), 606, 606.160(a), 610.40(a), 610.40(b), 610.41(a) |
| Inspection city | Johnston |
| Inspection ZIP | 50131 |
| Inspection start date | Jun 13, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: